Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interaction of Candesartan and Atorvastatin in Healthy Males
NCT02609711Phase 1Unknown
- Sponsor
- Ahn-Gook Pharmaceutical Co., Ltd.
- Start
- Nov 2015
- Primary completion
- Mar 2016
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of candesartan cilexetil and atorvastatin in hypertension (HTN) and hypercholesterolemia (3 arms), sponsored by Ahn-Gook Pharmaceutical Co., Ltd. Primary endpoints: Maximum Plasma Concentration (Cmax) of Candesartan cilexetil, Maximum Plasma Concentration (Cmax) of Atorvastatin and 2 more. Status: unknown.
02
Drugs
candesartan cilexetilatorvastatin
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT02609711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02609711.